BioSpace News Archive

Fostrox + Lenvima shows further improved response rates and time to progression in advanced liver cancer (HCC) at ASCO GI Symposium

Medivir AB announced further improved clinical benefit with fostrox + Lenvima® as data from the ongoing phase 1b/2a study in advanced hepatocellular carcinoma will be presented at the ASCO GI Symposium in San Francisco on January 19.

January 17, 2024
·
5 min read
Business

Samsung Bioepis Releases First Quarter 2024 US Biosimilar Market Report

Samsung Bioepis Co., Ltd. released its First Quarter 2024 Biosimilar Market Report which provides most timely information on the current status of biosimilars in the United States.

January 17, 2024
·
2 min read
Drug Development

TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously

Galderma announced positive topline results from the phase III READY-3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of glabellar lines and lateral canthal lines, either alone or simultaneously.

January 17, 2024
·
10 min read
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings

Pixium Vision SA announces that the decision of the Paris Commercial Court on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings has been postponed to a later date, which will be communicated by the Company as soon as it becomes aware of it.

January 17, 2024
·
1 min read
Lone Star Bio

Powered by Its Industry-Leading Comprehensive Multi-Modal Database, Caris Life Sciences to Showcase Research at ASCO Gastrointestinal Cancers Symposium 2024

Caris Life Sciences® announced that the company and collaborators within the Caris Precision Oncology Alliance™ will collectively present 11 studies across six solid tumor types at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium, January 18-20, 2024 in San Francisco.

January 17, 2024
·
6 min read
Biotech Bay

Gritstone bio to Participate in Upcoming Investor Conference

Gritstone bio, Inc. today announced that management will be participating in the following investor conference.

January 17, 2024
·
1 min read
Exero Medical’s Pivotal Clinical Study of xBar Approved by WCG in the US

Exero Medical’s prospective, blinded, multi-center study of xBar has been approved by the WCG.

January 17, 2024
·
2 min read
Biotech Bay

Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma

Veeva Systems (NYSE: VEEV) today announced a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture (EDC) application.

January 17, 2024
·
2 min read
Drug Development

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Acurx Pharmaceuticals, Inc. today announced positive comparative microbiology and microbiome data for ibezapolstat, its lead antibiotic candidate, from the Company’s recently completed Phase 2b clinical trial in patients with CDI.

January 17, 2024
·
14 min read
Deals

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2024

Seres Therapeutics, Inc. today announced that on January 10, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 67,500 shares of its common stock to one new employee.

January 17, 2024
·
1 min read